Successful Conversion Surgery in Advanced Hilar Cholangiocarcinoma Treated With Durvalumab Plus Gemcitabine and Cisplatin
Am Surg
.
2025 Jul;91(7):1217-1220.
doi: 10.1177/00031348251339534.
Epub 2025 Apr 29.
Authors
Kurumi Kiuchi
1
,
Nobuyuki Takemura
1
,
Akira Maki
1
,
Naganori Yamada
1
,
Noriki Okada
1
,
Masaki Yamamoto
1
,
Rihito Nagata
1
,
Wataru Yamamoto
2
,
Hiroki Imada
2
,
Morihiro Higashi
2
,
Riki Ninomiya
1
,
Akifumi Kimura
1
,
Taizen Urahashi
1
,
Saburo Matsubara
3
,
Yoshifumi Beck
1
Affiliations
1
Department of Hepato-Biliary-Pancreatic Surgery and Pediatric Surgery, Saitama Medical Center, Saitama Medical University, Kawagoe-shi, Japan.
2
Department of Pathology, Saitama Medical Center, Saitama Medical University, Kawagoe-shi, Japan.
3
Department of Gastroenterology and Hepatology, Saitama Medical Center, Saitama Medical University, Kawagoe-shi, Japan.
PMID:
40300188
DOI:
10.1177/00031348251339534
No abstract available
Keywords:
Conversion surgery; GCD therapy; Hilar cholangiocarcinoma.